Novartis Ag ADR (NVS)
$92.57
0.51 (0.55%)
NVS Stock Quote Delayed 30 Minutes
Anemic Earnings Growth Hurts Novartis AG (NVS) Rating
The current recommendation of Hold for Novartis AG (NYSE:NVS) has been derived by using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking NVS has had from Portfolio Grader for 2 months.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.05M
Day's Range
$92.35 - $92.91
52-Week Range
$92.19 - $108.78
Dividend & Yield
$3.47 (3.75%)
NVS Stock Predictions, Articles, and Novartis Ag ADR News
Immunize Juno Therapeutics Inc (JUNO) Stock With This Trade
JUNO stock has a lot going for it, but a bullish position looks a good deal better when fully-immunized with an options hedge.
3 Stocks to Watch on Tuesday: Boeing Co (BA), McDonald’s Corporation (MCD) and Novartis AG (ADR) (NVS)
Boeing (BA) has won a dispute with Airbus, McDonald's (MCD) workers strike in the US and UK and Novartis (NVS) names Van Narasimhan its CEO.
Novartis Wins FDA Approval for Groundbreaking Cancer Gene Therapy
Novartis (NVS) has garnered approval from the FDA for its groundbreaking cancer gene therapy, which will cost close to half a million.
United Therapeutics Corporation (UTHR) Shares Soar on Takeover Talk
United Therapeutics (UTHR) shares skyrocketed Friday amidst rumors that the company may be the subject of a takeover by a pharma giant soon.
Novartis AG (ADR) (NVS) Stock Pops on Solid Q2 Earnings
Novartis (NVS) stock got a boost on Tuesday with the release of positive results in its earnings report for the second quarter of 2017.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Nibble on Its Dividend and Wait
Teva Pharmaceutical (TEVA) is perhaps the poster child for what can go wrong with an investment. But TEVA stock is cheap and could double in price.
Is Teva Pharmaceutical Industries Ltd (ADR) Stock a Migraine Buy?
Teva's recent migraine drug data, while positive, didn't impress investors. What happened, and should you tussle with TEVA stock?
3 Cheap Biotech Stocks The Big Boys Are Buying (BLRX, OMED, FWP)
Biotechnology is among the most exciting and lucrative sectors for investors, and these 3 biotech stocks stand out...
Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Still Hot Garbage
Valeant Pharmaceuticals flipped to a profit in Q1, and VRX stock is jumping by double digits. But Valeant's long-term issues haven't budged.
Valeant Pharmaceuticals Intl Inc (VRX) Stock Won’t Keep This Rally Up
Valeant earnings are due out Tuesday morning, but it would take a laundry list of good news to sustain the rally in VRX stock.
Here’s How You Can Invest In The World’s Most Innovative Country: Switzerland (EWL)
I've uncovered a data set that show Switzerland as the most innovative country in the world. Here's how to take advantage...
Amgen, Inc. (AMGN) Q4 Earnings Preview
Amgen (AMGN) reports Q4 earnings on Thursday, and if something does weigh on AMGN stock, it'll likely be one of these three factors.
Amgen, Inc.: Capture Stronger Upside in AMGN Stock
Uncertainty, optimism and good liquidity are good reasons to consider an Amgen spread in lieu of AMGN stock in front of earnings.
Sleepy Johnson & Johnson (JNJ) Stock Could Finally Wake Up
If Johnson & Johnson (JNJ) deals for Actelion, it would be out of character. But it still could be a boon for JNJ stock.
PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril
Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there.
11 Pharmaceuticals Stocks to Sell Now
The ratings of 11 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Pharmaceuticals Stocks to Sell Now
This week, the overall grades of 11 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
